@semodough Would like more detail on ocular toxicity but its a known class effect already seen and manageable in other FGFR inhibitors already in commercial use (erdafitinib & pemigatinib). https://t.co/3fYhHjN318 These drugs require frequent optho vis
353 followers
381 followers
RT GUARDiONHealth: Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors https://t.co/4WlJbuh0ms
823 followers
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors https://t.co/GJ68y4rrQi